Immune Control's Series A - II Round

Immune Control raised a round of funding on August 21, 2009.

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor …

Articles about Immune Control's Series A - II Round: